SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,736,071 | +2.7% | 162,812 | -3.0% | 0.07% | +6.5% |
Q2 2023 | $19,221,953 | -30.9% | 167,848 | -16.9% | 0.06% | -38.0% |
Q1 2023 | $27,830,634 | +948.9% | 201,920 | +886.1% | 0.10% | +1566.7% |
Q4 2022 | $2,653,280 | +48.3% | 20,476 | +26.5% | 0.01% | +50.0% |
Q3 2022 | $1,789,000 | -68.1% | 16,184 | -78.4% | 0.00% | -55.6% |
Q2 2022 | $5,616,000 | -45.8% | 74,915 | -34.9% | 0.01% | +12.5% |
Q4 2021 | $10,361,000 | +1.3% | 115,055 | +4.0% | 0.01% | -27.3% |
Q3 2021 | $10,233,000 | +81.1% | 110,652 | +52.3% | 0.01% | +57.1% |
Q2 2021 | $5,649,000 | -50.3% | 72,659 | -52.4% | 0.01% | -58.8% |
Q1 2021 | $11,369,000 | -2.5% | 152,538 | +123.1% | 0.02% | -15.0% |
Q4 2020 | $11,657,000 | +201.3% | 68,372 | +148.1% | 0.02% | +66.7% |
Q3 2020 | $3,869,000 | +8.2% | 27,553 | -24.6% | 0.01% | -58.6% |
Q1 2020 | $3,575,000 | +1762.0% | 36,542 | +2352.5% | 0.03% | +2800.0% |
Q4 2019 | $192,000 | +79.4% | 1,490 | +4.9% | 0.00% | 0.0% |
Q3 2019 | $107,000 | -96.5% | 1,421 | -97.4% | 0.00% | -95.5% |
Q4 2017 | $3,085,000 | -65.0% | 55,446 | -71.5% | 0.02% | -72.5% |
Q3 2017 | $8,816,000 | +511.4% | 194,355 | +354.3% | 0.08% | +433.3% |
Q2 2017 | $1,442,000 | -60.3% | 42,782 | -65.1% | 0.02% | -64.3% |
Q1 2017 | $3,631,000 | -66.7% | 122,659 | -78.5% | 0.04% | -67.4% |
Q2 2016 | $10,892,000 | +787.7% | 571,145 | +808.4% | 0.13% | +658.8% |
Q1 2016 | $1,227,000 | -89.3% | 62,877 | -78.9% | 0.02% | -87.5% |
Q4 2015 | $11,501,000 | +17.6% | 298,111 | -2.1% | 0.14% | +0.7% |
Q3 2015 | $9,781,000 | +39.2% | 304,614 | +31.9% | 0.14% | +37.8% |
Q2 2015 | $7,029,000 | +293.1% | 230,996 | +71.6% | 0.10% | +250.0% |
Q1 2015 | $1,788,000 | -14.2% | 134,649 | -6.6% | 0.03% | -9.7% |
Q4 2014 | $2,085,000 | +22.1% | 144,105 | +78.0% | 0.03% | +19.2% |
Q3 2014 | $1,708,000 | +18.7% | 80,949 | +67.6% | 0.03% | +18.2% |
Q2 2014 | $1,439,000 | -35.7% | 48,307 | -48.1% | 0.02% | -42.1% |
Q1 2014 | $2,237,000 | -43.3% | 93,103 | -51.9% | 0.04% | -36.7% |
Q4 2013 | $3,945,000 | +804.8% | 193,678 | +1999.0% | 0.06% | +650.0% |
Q3 2013 | $436,000 | -81.2% | 9,227 | -84.8% | 0.01% | -86.0% |
Q2 2013 | $2,315,000 | – | 60,853 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |